A new study found that GLP-1 medications like Ozempic could have a major effect on COVID-19.

Researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the mechanism by which SARS-CoV-2, the virus that causes COVID-19, induces new cases of diabetes, and worsens ...

People with diabetes who have had COVID-19 tend to recover more slowly, experience more long COVID complications, have a poorer quality of life, and require closer and more prolonged monitoring by ...

Share on Pinterest Could GLP-1s hold the key to protecting people with diabetes against long COVID? Image credit: Jon Challicom/ Getty Images Some people develop long COVID after a SARS-CoV-2 ...